Third Harmonic Bio, Inc.

As of June 18, 2025, the market trend is neutral with mixed signals, showing mild bullishness on the weekly MACD and Bollinger Bands, but bearish momentum on the weekly RSI and monthly MACD, indicating no strong bullish or bearish momentum.

Third Harmonic Bio, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $16 million and a market cap of $245.50 million. Key metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -19.60%.

As of Jun 18, Third Harmonic Bio, Inc. has a market capitalization of 245.50 million, with net sales of 0.00 million and a net profit of -53.45 million for the latest four quarters. As of Dec'24, the company reported shareholder's funds of 285.15 million and total assets of 294.61 million.